Tru Independence LLC Editas Medicine, Inc. Transaction History

Tru Independence LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 20, 2021	SELL	$39.71 - $90.58 $4,407 - $10,054	-111 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$27.07 - $84.35 $3,004 - $9,362	111 New	111 $7,000
Q3 2020 Nov 19, 2020	SELL	$28.06 - $37.16 $25,534 - $33,815	-910 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$18.5 - $34.34 $16,835 - $31,249	910 New	910 $26,000

228

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $95.5M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.